registrieren | anmelden | FAQ      [?] 

Tag pharmacogenetics [94 articles]

Recent papers classified by the tag pharmacogenetics.
  • Candidate gene approach for pharmacogenetic studies.
    Pharmacogenomics, Vol. 3, No. 1. (January 2002), pp. 47-56.
    by HZ Ring, DL Kroetz
    posted to bioinformatics pharmacogenetics by ziquje on 2005-02-17 17:39:20 as **
  • Pharmacogenetics: improving drug and dose selection
    Current Opinion in Pharmacology, Vol. 8, No. 5. (October 2008), pp. 639-646.
    by A Bhathena, B Spear
    posted to selection pharmacogenetics genotyping efficacy effect dose adverse by zimbo1 on 2008-11-11 10:24:52 as **
  • notes Pharmacogenetics and Human Molecular Genetics of Opiate and Cocaine Addictions and Their Treatments
    Pharmacological Reviews, Vol. 57, No. 1. (1 March 2005), pp. 1-26.
    by MJ Kreek, G Bart, C Lilly, KS Laforge, DA Nielsen
    posted to cocaine genotype opioids pharmacogenetics by shupsy on 2007-07-04 23:16:40 as **
  • notes Gene expression evidence for remodeling of lateral hypothalamic circuitry in cocaine addiction
    PNAS, Vol. 102, No. 32. (9 August 2005), pp. 11533-11538.
    by Serge H Ahmed, Robert Lutjens, Lena D van der Stap, Dusan Lekic, Vincenzo Romano-Spica, Marisela Morales, George F Koob, Vez Repunte-Canonigo, Pietro P Sanna
    posted to cocaine gene-expression genotype pharmacogenetics by shupsy on 2007-07-04 23:15:43 as ***
  • Pharmacogenetics in drug discovery and development: a translational perspective
    Nature Reviews Drug Discovery, Vol. 7, No. 10. (19 September 2008), pp. 807-817.
    by Allen D Roses
    posted to trials translational pharmacogenetics medicine drug discovery clinical by sg45653 on 2008-10-02 01:04:07 as ** along with 4 people guhjy nicklynch pengchy dunnma
  • Pharmacogenetics as Alien Science: Alzheimer's Disease, Core Sets and Expectations
    Social Studies of Science, Vol. 36, No. 5. (1 October 2006), pp. 723-752.
    by Adam Hedgecoe
    posted to expectations pharmacogenetics sociology ssk by ricmilne on 2006-09-06 10:57:30 as read along with 1 group STS
  • The diffusion of innovation: factors influencing the uptake of pharmacogenetics.
    Community Genet, Vol. 10, No. 4. (2007), pp. 231-241.
    by LF Nielsen, C Moldrup
    posted to attitudes personalized-medicine pharmacogenetics public-opinion survey-research by PredictER on 2007-10-09 19:08:31 as **
  • Pharmacogenetics of warfarin: regulatory, scientific, and clinical issues.
    J Thromb Thrombolysis (1 October 2007)
    by Brian F Gage, Lawrence J Lesko
    posted to clinical-ethics elsi pharmacogenetics policy warfarin by PredictER on 2007-10-08 01:10:59 as ** along with 1 person jasonbobe
  • Patients' and healthcare professionals' views on pharmacogenetic testing and its future delivery in the NHS.
    Pharmacogenomics, Vol. 8, No. 11. (November 2007), pp. 1511-1519.
    by Emily A A Fargher, Charlotte Eddy, William Newman, Faieza Qasim, Karen Tricker, Rachel A A Elliott, Katherine Payne
    posted to attitudes genetic-testing health-professionals patients pharmacogenetics by PredictER on 2007-12-10 00:02:40 as **
  • Ancillary risk information and pharmacogenetic tests: social and policy implications
    The Pharmacogenomics Journal, Vol. aop, No. current.
    by NB Henrikson, W Burke, DL Veenstra
    posted to ethical-issues genetic-testing pharmacogenetics policy risk by PredictER on 2008-04-04 17:00:57 as ** along with 2 people elsiatcase jasonbobe
  • Pharmacogenetic testing: not as simple as it seems.
    Genetics in medicine : official journal of the American College of Medical Genetics (16 May 2008)
    by Susanne B Haga, Wylie Burke
    posted to ethical-issues genetic-testing pharmacogenetics by PredictER on 2008-06-05 17:58:52 as **
  • Anticipating clinical integration of genetically tailored tobacco dependence treatment: perspectives of primary care physicians.
    Nicotine Tob Res, Vol. 9, No. 2. (February 2007), pp. 271-279.
    by ER Park, S Kleimann, JA Pelan, AE Shields
    posted to addiction personalized-medicine pharmacogenetics smoking by PredictER on 2007-10-03 04:53:50 as ** along with 1 person elsiatcase
  • Routine pharmacogenetic testing in clinical practice: dream or reality?
    Pharmacogenomics, Vol. 8, No. 10. (October 2007), pp. 1449-1459.
    by Grossman, Iris
    posted to genetic-testing personalized-medicine pharmacogenetics by PredictER on 2007-11-11 22:34:12 as **
  • Pharmacogenetics: From Bench to Byte.
    Clin Pharmacol Ther (6 February 2008)
    by Jj Swen, I Wilting, Al de D Goede, L Grandia, H Mulder, Dj Touw, A de D Boer, Jmh Conemans, Tcg Egberts, Oh Klungel, R Koopmans, J van der V Weide, B Wilffert, H-J J Guchelaar, Vhm Deneer
    posted to personalized-medicine pharmacogenetics translational-research by PredictER on 2008-02-20 02:11:42 as ** along with 1 person jasonbobe
  • Genomics and the future of pharmacotherapy in psychiatry.
    Int Rev Psychiatry, Vol. 19, No. 5. (October 2007), pp. 523-530.
    by AK Malhotra, T Lencz, CU Correll, JM Kane
    posted to genetic-research personalized-medicine pharmacogenetics psychiatry by PredictER on 2007-10-09 19:48:54 as **
  • Genetic databases and pharmacogenetics: introduction.
    Studies in history and philosophy of biological and biomedical sciences, Vol. 37, No. 3. (September 2006), pp. 499-502.
    by RE Ashcroft, AM Hedgecoe
    posted to biobanks ethical-issues pharmacogenetics by PredictER on 2008-04-08 22:19:22 as **
  • From human genetics and genomics to pharmacogenetics and pharmacogenomics: past lessons, future directions.
    Drug metabolism reviews, Vol. 40, No. 2. (2008), pp. 187-224.
    by DW Nebert, G Zhang, ES Vesell
    posted to personalized-medicine pharmacogenetics pharmacogenomics by PredictER on 2008-06-05 17:51:55 as ** along with 1 person and 1 group Zephyrus Roswell Cancer Crosstalk
  • Human leukocyte antigens and drug hypersensitivity.
    Current opinion in allergy and clinical immunology, Vol. 7, No. 4. (August 2007), pp. 317-323.
    by WH Chung, SI Hung, YT Chen
    posted to review pharmacogenetics hla adr by misonneh on 2008-11-07 06:28:34 as **
  • Gene testing to tailor breast cancer therapy has arrived--is it ready for the clinic?
    Journal of the National Cancer Institute, Vol. 100, No. 15. (6 August 2008), pp. 1050-1051.
    by G Sinha
    posted to tamoxifen pharmacogenetics cyp2d6 breast by misonneh on 2008-09-16 21:30:22 as **
  • Induction and expression of GST-Pi foci in the liver of Cyclophosphamide-administered rats.
    Toxicology, Vol. 217, No. 2-3. (16 January 2006), pp. 120-128.
    by A Devi, H Devaraj
    posted to therapy pharmacogenetics invivo gstp1 epigenetics cyclophosphamide by misonneh on 2008-10-17 16:52:41 as **
  • Circulating tumor-specific DNA: a marker for monitoring efficacy of adjuvant therapy in cancer patients.
    Cancer research, Vol. 65, No. 4. (15 February 2005), pp. 1141-1145.
    by H Fiegl, S Millinger, E Mueller-Holzner, C Marth, C Ensinger, A Berger, H Klocker, G Goebel, M Widschwendter
    posted to tamoxifen progression prognosis pharmacogenetics circ_dna breast biomarker by misonneh on 2008-10-08 23:19:52 as ** along with 1 person c70238
  • Toward individualized treatment: prediction of anticancer drug disposition and toxicity with pharmacogenetics.
    Anti-cancer drugs, Vol. 18, No. 2. (February 2007), pp. 111-126.
    by JF Deeken, WD Figg, SE Bates, A Sparreboom
    posted to toxicity review pharmacogenetics by misonneh on 2008-10-29 10:16:18 as **
  • Randomized, Controlled Trial of Cyclophosphamide, Methotrexate, and Fluorouracil Versus Cyclophosphamide, Doxorubicin, and Fluorouracil With and Without Tamoxifen for High-Risk, Node-Negative Breast Cancer: Treatment Results of Intergroup Protocol INT-0102
    J Clin Oncol, Vol. 23, No. 33. (20 November 2005), pp. 8313-8321.
    by Laura F Hutchins, Stephanie J Green, Peter M Ravdin, Danika Lew, Silvana Martino, Martin Abeloff, Alan P Lyss, Craig Allred, Saul E Rivkin, Kent C Osborne
    posted to swog s8897 pharmacogenetics parent_study by misonneh on 2008-09-17 18:19:33 as read
  • Generating mutations but providing chemosensitivity: the role of O6-methylguanine DNA methyltransferase in human cancer.
    Oncogene, Vol. 23, No. 1. (8 January 2004), pp. 1-8.
    by M Esteller, JG Herman
    posted to therapy resistance pharmacogenetics mgmt genetics gene_specific_methylation by misonneh on 2008-10-17 16:51:20 as **
  • The role of genetic variability in drug metabolism pathways in breast cancer prognosis
    Pharmacogenomics, Vol. 7, No. 4. (June 2006), pp. 613-624.
    by Choi, Ji-Yeob, Nowell, A Susan, Blanco, G Javier, Ambrosone, B Christine
    posted to review pharmacogenetics breast by misonneh on 2008-09-24 20:11:50 as read
  • A European study of HLA-B in Stevens-Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs.
    Pharmacogenetics and genomics, Vol. 18, No. 2. (February 2008), pp. 99-107.
    by C Lonjou, N Borot, P Sekula, N Ledger, L Thomas, S Halevy, L Naldi, JN Bouwes-Bavinck, A Sidoroff, C de Toma, M Schumacher, JC Roujeau, A Hovnanian, M Mockenhaupt,
    posted to pharmacogenetics hla carbamazepine adr by misonneh on 2008-11-06 06:16:00 as read
  • Common germline genetic variation in antioxidant defense genes and survival after diagnosis of breast cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 25, No. 21. (20 July 2007), pp. 3015-3023.
    by M Udler, AT Maia, A Cebrian, C Brown, D Greenberg, M Shah, C Caldas, A Dunning, D Easton, B Ponder, P Pharoah
    posted to survival pharmacogenetics genetics breast antioxidant by misonneh on 2008-09-23 21:17:33 as **
  • Cancer pharmacogenetics: polymorphisms, pathways and beyond.
    Nature reviews. Cancer, Vol. 3, No. 12. (December 2003), pp. 912-920.
    by CM Ulrich, K Robien, HL McLeod
    posted to review pharmacogenetics 1-carbon by misonneh on 2008-09-24 18:41:19 as **
  • The reemergence of nitric oxide and cancer.
    Nitric oxide : biology and chemistry / official journal of the Nitric Oxide Society, Vol. 19, No. 2. (September 2008), pp. 65-67.
    by DA Wink, LA Ridnour, SP Hussain, CC Harris
    posted to review pharmacogenetics nos3 no by misonneh on 2008-09-29 17:55:43 as read
  • Adjuvant therapy for very young women with breast cancer: need for tailored treatments.
    Journal of the National Cancer Institute. Monographs, No. 30. (2001), pp. 44-51.
    by A Goldhirsch, RD Gelber, G Yothers, RJ Gray, S Green, J Bryant, S Gelber, M Castiglione-Gertsch, AS Coates
    posted to review pharmacogenetics breast by misonneh on 2008-10-29 10:21:53 as **
  • Severe cutaneous adverse reactions to drugs.
    Current opinion in allergy and clinical immunology, Vol. 7, No. 4. (August 2007), pp. 304-309.
    by FL Chia, KP Leong
    posted to review pharmacogenetics adr by misonneh on 2008-11-07 06:29:36 as **
  • HLA class I and II gene polymorphisms in Stevens-Johnson syndrome with ocular complications in Japanese.
    Molecular vision, Vol. 14 (2008), pp. 550-555.
    by M Ueta, K Tokunaga, C Sotozono, T Inatomi, T Yabe, M Matsushita, Y Mitsuishi, S Kinoshita
    posted to race pharmacogenetics hla carbamazepine adr by misonneh on 2008-11-06 06:15:23 as **
  • "Stemness" genomics law governs clinical behavior of human cancer: implications for decision making in disease management.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 26, No. 17. (10 June 2008), pp. 2846-2853.
    by GV Glinsky
    posted to review pharmacogenetics genetics epigenetics by misonneh on 2008-10-14 14:59:17 as ** along with 1 person ajaymalik
  • HLA-B locus in Caucasian patients with carbamazepine hypersensitivity
    Pharmacogenomics, Vol. 7, No. 6. (September 2006), pp. 813-818.
    by Alfirevic, Ana, Jorgensen, L Andrea, Williamson, R Paula, Chadwick, W David, Park, B Kevin, Pirmohamed, Munir
    posted to race pharmacogenetics hla carbamazepine adr by misonneh on 2008-11-06 06:18:05 as **
  • Methylation-dependent silencing of the reduced folate carrier gene in inherently methotrexate-resistant human breast cancer cells.
    The Journal of biological chemistry, Vol. 276, No. 43. (26 October 2001), pp. 39990-40000.
    by J Worm, AF Kirkin, KN Dzhandzhugazyan, P Guldberg
    posted to rfc resistance pharmacogenetics mrp3 methylation methotrexate mdr1 folate breast by misonneh on 2008-09-23 21:14:51 as **
  • Genomics and circulating tumor cells: promising tools for choosing and monitoring adjuvant therapy in patients with early breast cancer?
    Current opinion in oncology, Vol. 17, No. 6. (November 2005), pp. 551-558.
    by L Dirix, P Van Dam, P Vermeulen
    posted to review pharmacogenetics diagnosis circ_dna breast blood biomarker by misonneh on 2008-10-08 23:18:33 as **
  • Strong association between HLA-A*0206 and Stevens-Johnson syndrome in the Japanese.
    American journal of ophthalmology, Vol. 143, No. 2. (February 2007), pp. 367-368.
    by M Ueta, C Sotozono, K Tokunaga, T Yabe, S Kinoshita
    posted to race pharmacogenetics hla carbamazepine adr by misonneh on 2008-11-06 06:17:23 as ****
  • Pharmacogenomic variation of CYP2D6 and the choice of optimal adjuvant endocrine therapy for postmenopausal breast cancer: a modeling analysis.
    Journal of the National Cancer Institute, Vol. 100, No. 9. (7 May 2008), pp. 642-648.
    by RS Punglia, HJ Burstein, EP Winer, JC Weeks
    posted to tamoxifen resistance pharmacogenetics modeling cyp2d6 breast by misonneh on 2008-09-16 21:31:38 as *****
  • Breast cancer treatment outcome with adjuvant tamoxifen relative to patient CYP2D6 and CYP2C19 genotypes.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 25, No. 33. (20 November 2007), pp. 5187-5193.
    by W Schroth, L Antoniadou, P Fritz, M Schwab, T Muerdter, UM Zanger, W Simon, M Eichelbaum, H Brauch
    posted to tamoxifen pharmacogenetics cyp2d6 cyp2c19 breast by misonneh on 2008-09-16 21:33:40 as **
  • Carbamazepine, HLA-B*1502 and risk of StevensJohnson syndrome and toxic epidermal necrolysis: US FDA recommendations
    Pharmacogenomics, Vol. 9, No. 10. (October 2008), pp. 1543-1546.
    by Ferrell, P Brent, Mcleod, L Howard
    posted to review race pharmacogenetics hla carbamazepine adr by misonneh on 2008-11-06 06:14:18 as ****
  • Don Quixote and the quest for personalized medicine.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 26, No. 16. (1 June 2008), pp. 2619-2620.
    by CJ Allegra, JK Benedetti
    posted to pharmacogenetics comments colon chemotherapy by misonneh on 2008-10-29 10:20:25 as **
  • Association of DNA methylation of phosphoserine aminotransferase with response to endocrine therapy in patients with recurrent breast cancer.
    Cancer research, Vol. 65, No. 10. (15 May 2005), pp. 4101-4117.
    by JW Martens, I Nimmrich, T Koenig, MP Look, N Harbeck, F Model, A Kluth, J Bolt-de Vries, AM Sieuwerts, H Portengen, ME Meijer-Van Gelder, C Piepenbrock, A Olek, H Höfler, M Kiechle, JG Klijn, M Schmitt, S Maier, JA Foekens
    posted to tamoxifen resistance pharmacogenetics methylation breast by misonneh on 2008-09-23 21:16:26 as **
  • Role of mismatch repair and MGMT in response to anticancer therapies.
    Anti-cancer agents in medicinal chemistry, Vol. 8, No. 4. (May 2008), pp. 368-380.
    by I Casorelli, MT Russo, M Bignami
    posted to pharmacogenetics mgmt by misonneh on 2008-09-23 19:12:41 as **
  • Predictive biomarkers of chemotherapy efficacy in colorectal cancer: results from the UK MRC FOCUS trial.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 26, No. 16. (1 June 2008), pp. 2690-2698.
    by MS Braun, SD Richman, P Quirke, C Daly, JW Adlard, F Elliott, JH Barrett, P Selby, AM Meade, RJ Stephens, MK Parmar, MT Seymour
    posted to pharmacogenetics colon clinic chemotherapy biomarker by misonneh on 2008-10-29 10:19:17 as **
  • Re: Pharmacogenomic variation of CYP2D6 and the choice of optimal adjuvant endocrine therapy for postmenopausal breast cancer: a modeling analysis.
    Journal of the National Cancer Institute, Vol. 100, No. 18. (17 September 2008)
    by D Gurwitz, W Newman
    posted to tamoxifen survival pharmacogenetics modeling cyp2d6 comments breast by misonneh on 2008-11-19 05:17:27 as **
  • Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions.
    Pharmacogenetics and genomics, Vol. 16, No. 4. (April 2006), pp. 297-306.
    by SI Hung, WH Chung, SH Jee, WC Chen, YT Chang, WR Lee, SL Hu, MT Wu, GS Chen, TW Wong, PF Hsiao, WH Chen, HY Shih, WH Fang, CY Wei, YH Lou, YL Huang, JJ Lin, YT Chen
    posted to review race pharmacogenetics hla carbamazepine adr by misonneh on 2008-11-06 06:18:43 as **
  • Influence of cytochrome P450 polymorphisms on drug therapies: Pharmacogenetic, pharmacoepigenetic and clinical aspects.
    Pharmacol Ther, Vol. 116, No. 3. (December 2007), pp. 496-526.
    by M Ingelman-Sundberg, SC Sim, A Gomez, C Rodriguez-Antona
    posted to therapy review pharmacogenetics cyp by misonneh on 2008-11-11 13:53:56 as *****
  • Pharmacogenetics: ethical issues and policy options.
    Kennedy Inst Ethics J, Vol. 12, No. 1. (March 2002), pp. 1-15.
    by A Buchanan, A Califano, J Kahn, E McPherson, J Robertson, B Brody
    posted to pharmacogenetics by ladygoat on 2005-03-28 17:44:25 as ** along with 1 group CGREL
  • Protecting communities in pharmacogenetic and pharmacogenomic research.
    Pharmacogenomics J, Vol. 4, No. 1. (2004), pp. 9-16.
    by C Weijer, PB Miller
    posted to pharmacogenetics by ladygoat on 2005-03-28 17:56:44 as ** along with 1 person and 1 group evoltropia CGREL
  • Opinion: Pharmacogenetics and geographical ancestry: implications for drug development and global health
    Nature Reviews Genetics, Vol. 6, No. 3. (01 March 2005), pp. 241-246.
    by Abdallah S Daar, Peter A Singer
    posted to pharmacogenetics by ladygoat on 2005-03-28 18:10:24 as ** along with 1 group CGREL
    • Bemerkung: Sie können diese Seite wie folgt zitieren: http://www.citeulike.org/tag/pharmacogenetics

    Result page: 1 2 Next RIS BibTeX
    CiteULike organises scholarly (or academic) papers or literature and provides bibliographic (which means it makes bibliographies) for universities and higher education establishments. It helps undergraduates and postgraduates. People studying for PhDs or in postdoctoral (postdoc) positions. The service is similar in scope to EndNote or RefWorks or any other reference manager like BibTeX, but it is a social bookmarking service for scientists and humanities researchers.